Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deping Wang

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2017
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>v</sub>1.7 inhibitors with pain efficacy in miceAnthony J Roecker, Melissa Egbertson, Kristen L G Jones, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2011
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)Lin Zhang, Junhua Fan, Jer-Hong Chong, et al.
Science Translational Medicine|February 22, 2023
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1Carl J Balibar, Daniel J Klein, Beata Zamlynny, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of MK-5661, a Once-Daily Oral Na<sub>V</sub>1.8 Inhibitor for the Treatment of PainChristopher J Bungard, Michael J Breslin, Christopher W Boyce, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2017
Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>v</sub>1.7 inhibitors with pain efficacy in miceAnthony J Roecker, Melissa Egbertson, Kristen L G Jones, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2011
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)Lin Zhang, Junhua Fan, Jer-Hong Chong, et al.
Science Translational Medicine|February 22, 2023
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1Carl J Balibar, Daniel J Klein, Beata Zamlynny, et al.
Journal of Medicinal Chemistry|December 21, 2021
Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na<sub>v</sub>1.7 for the Treatment of PainGregory L Adams, Parul S Pall, Steven M Grauer, et al.
Pageof 17